Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder associated with significant metabolic and reproductive dysfunction. Although metformin has long been a cornerstone of PCOS management, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have emerged as promising alternatives, particularly for improving metabolic outcomes. This systematic review and meta-analysis aimed to evaluate the effects of GLP-1 RAs compared with metformin on metabolic, hormonal, and reproductive...
Published on: Tue, 24 Mar 2026 06:00:00 -0400
Authors: Khuloud Almubaddil, Manal Alotaibi, Lena Bin Mutreb, Fouz Alanazi, Msaad Altulihee,
The primary objective of polycystic ovarian syndrome (PCOS) treatment is to achieve mono-ovulatory cycles, thereby enabling pregnancy and childbirth. Laparoscopic ovarian drilling (LOD) and transvaginal ovarian drilling (TVOD) are widely used second-line treatments for ovulation induction in PCOS patients who do not respond to clomiphene citrate (CC). LOD involves the application of heat or laser energy to create small perforations in the ovary, whereas TVOD involves ultrasound-guided ovarian...
Published on: Tue, 24 Mar 2026 06:00:00 -0400
Authors: Mah Rukh Afzal, Mohamed Alassar, Ariba Furqan, Linh Huynh, Maher Feras Alnajjar, Safa Gismalla, Ibrahim Mostafa Hussein, Adel Mahmah,
CONCLUSIONS: PCOS is a frequent cause of both PA and SA in adolescents. Girls with PA exhibit greater hyperandrogenism and are more likely to fail a progesterone challenge, suggesting a more severe phenotype than in those with SA.
Published on: Mon, 23 Mar 2026 06:00:00 -0400
Authors: Manahil Mustafa, Erica A Eugster,
Ursolic Acid (UA), a naturally occurring pentacyclic triterpene, was isolated from Ochrosia elliptica. Polycystic Ovary Syndrome (PCOS) a prevalent endocrine disorder characterized by hyperandrogenism, insulin resistance, and chronic inflammation. In this study, we investigate the role of UA in alleviating the symptoms of PCOS, focusing on its biochemical, hormonal, and histopathological effects in a rat model. Using adult female Wistar Albino rats, PCOS was induced through letrozole...
Published on: Mon, 23 Mar 2026 06:00:00 -0400
Authors: Shimaa R Emam, Marwa A Ibrahim, Fady Sayed Youssef, Marwa S Khattab, Riham A El-Shiekh, Rehab A Ghandour, Heba F Hozyen, Marwa Zakaria, Essam A Abdel-Sattar, Samar M Mouneir,
Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder manifested by hyperandrogenism, ovulatory dysfunction, and systemic metabolic dysregulation. While the 'gut-diet' axis offers potential therapeutic avenues, the synergistic molecular mechanisms integrating dietary flavonoids and gut microbiota remain elusive. This study employed a comprehensive network pharmacology approach, coupled with molecular docking validation, to decode the tripartite interaction network of 'Dietary...
Published on: Mon, 23 Mar 2026 06:00:00 -0400
Authors: Hong Chen, Hongying Kuang, Yang Zhang, Qionghua Chen, Dongxia Yang,
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder associated with insulin resistance and affecting women of reproductive age. Although the aetiology and the underlying molecular mechanisms of metabolic dysregulation in PCOS remain unclear, regular physical activity is known to ameliorate metabolic dysfunction. In this study, we investigated the transcriptional and epigenetic adaptations to exercise training in women with PCOS (n = 8). Following 12 weeks of high-intensity...
Published on: Mon, 23 Mar 2026 06:00:00 -0400
Authors: Alba Moreno-Asso, Ali Altıntaş, Sarah Voisin, Luke C McIlvenna, Rhiannon K Patten, Andrew J McAinch, Raymond Joseph Rodgers, Nigel K Stepto, Romain Barrès,
Polycystic Ovary Syndrome (PCOS) persists across the lifespan, yet management during perimenopause and menopause remains underexplored. This scoping review examined non-pharmacological and non-surgical interventions for adult women with PCOS, with particular attention to lifestyle modifications, complementary approaches, and the influence of chronic pain and mental health on quality of life. Guided by the Arksey and O'Malley five-step framework and Joanna Briggs Institute recommendations,...
Published on: Mon, 23 Mar 2026 06:00:00 -0400
Authors: Candy Wilson, Lenny Chiang-Hanisko, Sahar Kaleem, Moradi Aljadani, Jennifer Mendonca, Shaima Arshad, Nicole Pirrone, Tiffany Follin, Lea Sacca,
CONCLUSION: A minimum combination of ovarian volume with AMH and examination/history-derived end points can accurately predict PCOS diagnosis with performance comparable to that of a combination of all ultrasonographic, biochemical, and clinical features. This may streamline diagnostic workflows, thereby reducing clinical burden.
Published on: Mon, 23 Mar 2026 06:00:00 -0400
Authors: Adam T Evans, Eeshaan Rehani, Bailey Smith, Melody D Hong, Zoe Lewin, Karina Hiroshige, Steven D Spandorfer, Iman Hajirasouliha, Marla E Lujan, Kathleen M Hoeger,
CONCLUSION: This MR study provides evidence supporting a potential causal association between genetically predicted PCOS and GDM in East Asian populations, in contrast to previous European-based findings, and highlights possible population-specific genetic differences with implications for precision risk assessment in pregnancy.
Published on: Mon, 23 Mar 2026 06:00:00 -0400
Authors: Jingshu Du, Liwei Xing, Yang Chen, Zhe He, Lanping Zhong, Rong Zhao,
Edible bird's nest (EBN) is a traditional functional food consumed for its purported reproductive health benefits. However, robust preclinical evidence supporting its efficacy in polycystic ovary syndrome (PCOS)-a prevalent endocrine disorder characterized by hyperandrogenism and gonadotropin dysregulation-is lacking. This study aimed to evaluate the effects of a commercially available fresh EBN product on reproductive endocrine, metabolic, and ovarian parameters in a letrozole-induced PCOS rat...
Published on: Mon, 23 Mar 2026 06:00:00 -0400
Authors: Yang Jiao, Man Yuan, Liqin Chen, Shuang Qiu, Juan Chen, Dongliang Wang,
Polyethylene terephthalate microplastics (PET-MPs) function as endocrine-disrupting agents that interfere with steroidogenesis and folliculogenesis, potentially contributing to polycystic ovary syndrome (PCOS). This study integrates computational toxicology and machine learning to delineate the mechanisms linking PET-MP exposure to PCOS pathogenesis. We conducted systematic multi-omics analysis by merging PET-MP-associated targets from ChemBL, PubChem, SwissTargetPrediction, SuperPred, and...
Published on: Sun, 22 Mar 2026 06:00:00 -0400
Authors: Hai Bai, Yuxiao Jiang, Bozhi Zhu, Jing Huang, Yu Zhang, Xunrui Liu, Liying Ge, Shanshan Zhang, Yue Shi, Mingming Wang,
No abstract
Published on: Sun, 22 Mar 2026 06:00:00 -0400
Authors: DongXue Wang, JingNa Wang, Bo Yang, Xin Zhao, Xiaoye Feng, Qi Ding, Yuanyuan Wu, LiLi Bao,
No abstract
Published on: Sun, 22 Mar 2026 06:00:00 -0400
Authors: Mirfat Mohamed Labib Elkashif, Sally Abd-Elrahman Mohamed, SHaheena Tabassum Mohammad Ahsan, Darelglal Ahmed Gassmelseed, Shimaa Mohamed Mohamed Koabar, Doaa Mostafa Sheashaa,
CONCLUSION: The prevalence of GDM in women with PCOS is similar between those treated for infertility and those not treated. Other determinants of GDM within this population have been identified, which could potentially enable early detection of women at risk and the implementation of personalized care in a precision medicine approach.
Published on: Sat, 21 Mar 2026 06:00:00 -0400
Authors: Alice Mionnet, Nassima Ramdane, Anne Vambergue, Sophie Catteau-Jonard, Geoffroy Robin, Christine Decanter, Madleen Lemaitre,
CONCLUSIONS: Combined finasteride and spironolactone significantly improved all HRQOL scales and reduced hyperandrogenism within the first four months in women with PCOS, supporting its role alongside lifestyle measures.
Published on: Sat, 21 Mar 2026 06:00:00 -0400
Authors: Samih Abed Odhaib, Mahmood Thamer Altemimi, Adel Gassab Mohammed, Dheyaa Kadhim Al-Waeli, Miaad Jassim Mohammed, Haider Ayad Alidrisi, Husam Jihad Imran, Abbas Ali Mansour,